nodes	percent_of_prediction	percent_of_DWPC	metapath
Amitriptyline—CYP3A5—prostate cancer	0.099	0.357	CbGaD
Amitriptyline—CYP2E1—prostate cancer	0.068	0.245	CbGaD
Amitriptyline—CYP2C19—prostate cancer	0.0674	0.243	CbGaD
Amitriptyline—CYP3A4—prostate cancer	0.0428	0.155	CbGaD
Amitriptyline—ORM1—Abiraterone—prostate cancer	0.0356	0.0843	CbGbCtD
Amitriptyline—ALB—Abiraterone—prostate cancer	0.015	0.0355	CbGbCtD
Amitriptyline—CYP2C8—Nilutamide—prostate cancer	0.014	0.0331	CbGbCtD
Amitriptyline—CYP3A5—Flutamide—prostate cancer	0.012	0.0285	CbGbCtD
Amitriptyline—CYP2C19—Bicalutamide—prostate cancer	0.0117	0.0277	CbGbCtD
Amitriptyline—CYP2C19—Nilutamide—prostate cancer	0.0117	0.0277	CbGbCtD
Amitriptyline—CYP2C8—Abiraterone—prostate cancer	0.0116	0.0274	CbGbCtD
Amitriptyline—CYP2E1—Estrone—prostate cancer	0.0112	0.0265	CbGbCtD
Amitriptyline—CYP2B6—Estrone—prostate cancer	0.0111	0.0262	CbGbCtD
Amitriptyline—ALB—Estrone—prostate cancer	0.0108	0.0256	CbGbCtD
Amitriptyline—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0108	0.0255	CbGbCtD
Amitriptyline—CYP2B6—Ethinyl Estradiol—prostate cancer	0.00985	0.0233	CbGbCtD
Amitriptyline—CYP2C9—Nilutamide—prostate cancer	0.00975	0.0231	CbGbCtD
Amitriptyline—CYP2C9—Bicalutamide—prostate cancer	0.00975	0.0231	CbGbCtD
Amitriptyline—CYP2C19—Flutamide—prostate cancer	0.00972	0.023	CbGbCtD
Amitriptyline—CYP1A2—Flutamide—prostate cancer	0.00897	0.0212	CbGbCtD
Amitriptyline—CYP2D6—Bicalutamide—prostate cancer	0.00892	0.0211	CbGbCtD
Amitriptyline—CYP3A5—Cabazitaxel—prostate cancer	0.00891	0.0211	CbGbCtD
Amitriptyline—ABCB1—Estramustine—prostate cancer	0.0088	0.0208	CbGbCtD
Amitriptyline—CYP3A5—Estrone—prostate cancer	0.00871	0.0206	CbGbCtD
Amitriptyline—ADRA1B—vas deferens—prostate cancer	0.00862	0.157	CbGeAlD
Amitriptyline—CYP2C8—Cabazitaxel—prostate cancer	0.00857	0.0203	CbGbCtD
Amitriptyline—CYP2C8—Ethinyl Estradiol—prostate cancer	0.00746	0.0177	CbGbCtD
Amitriptyline—CYP2D6—Abiraterone—prostate cancer	0.00739	0.0175	CbGbCtD
Amitriptyline—CYP2E1—Mitoxantrone—prostate cancer	0.00667	0.0158	CbGbCtD
Amitriptyline—CYP1A2—Estrone—prostate cancer	0.00648	0.0153	CbGbCtD
Amitriptyline—ALB—Estradiol—prostate cancer	0.00622	0.0147	CbGbCtD
Amitriptyline—CYP2C9—Estrone—prostate cancer	0.00584	0.0138	CbGbCtD
Amitriptyline—ABCB1—Cabazitaxel—prostate cancer	0.0058	0.0137	CbGbCtD
Amitriptyline—CYP3A4—Bicalutamide—prostate cancer	0.00567	0.0134	CbGbCtD
Amitriptyline—ABCB1—Estrone—prostate cancer	0.00567	0.0134	CbGbCtD
Amitriptyline—ALB—Prednisone—prostate cancer	0.00535	0.0127	CbGbCtD
Amitriptyline—CYP3A4—Estramustine—prostate cancer	0.00527	0.0125	CbGbCtD
Amitriptyline—ABCB1—Ethinyl Estradiol—prostate cancer	0.00505	0.0119	CbGbCtD
Amitriptyline—HTR7—vas deferens—prostate cancer	0.00502	0.0915	CbGeAlD
Amitriptyline—CYP3A5—Estradiol—prostate cancer	0.005	0.0118	CbGbCtD
Amitriptyline—CYP2C8—Estradiol—prostate cancer	0.00481	0.0114	CbGbCtD
Amitriptyline—CYP3A4—Flutamide—prostate cancer	0.0047	0.0111	CbGbCtD
Amitriptyline—CYP3A4—Abiraterone—prostate cancer	0.0047	0.0111	CbGbCtD
Amitriptyline—CYP2C9—Capecitabine—prostate cancer	0.00443	0.0105	CbGbCtD
Amitriptyline—CYP1A2—Conjugated Estrogens—prostate cancer	0.00424	0.01	CbGbCtD
Amitriptyline—CYP2E1—Etoposide—prostate cancer	0.0042	0.00994	CbGbCtD
Amitriptyline—CHRM3—ureter—prostate cancer	0.00404	0.0736	CbGeAlD
Amitriptyline—CYP2C19—Estradiol—prostate cancer	0.00404	0.00954	CbGbCtD
Amitriptyline—CYP1A2—Estradiol—prostate cancer	0.00372	0.00881	CbGbCtD
Amitriptyline—ABCB1—Conjugated Estrogens—prostate cancer	0.00371	0.00877	CbGbCtD
Amitriptyline—CYP3A4—Cabazitaxel—prostate cancer	0.00347	0.00822	CbGbCtD
Amitriptyline—CYP2C19—Prednisone—prostate cancer	0.00347	0.00821	CbGbCtD
Amitriptyline—CYP3A4—Estrone—prostate cancer	0.0034	0.00803	CbGbCtD
Amitriptyline—ABCB1—Mitoxantrone—prostate cancer	0.00337	0.00797	CbGbCtD
Amitriptyline—CYP2C9—Estradiol—prostate cancer	0.00335	0.00793	CbGbCtD
Amitriptyline—CYP3A5—Etoposide—prostate cancer	0.00327	0.00773	CbGbCtD
Amitriptyline—ABCB1—Estradiol—prostate cancer	0.00326	0.0077	CbGbCtD
Amitriptyline—CYP2C8—Etoposide—prostate cancer	0.00314	0.00743	CbGbCtD
Amitriptyline—CYP3A4—Ethinyl Estradiol—prostate cancer	0.00303	0.00716	CbGbCtD
Amitriptyline—CYP3A5—Docetaxel—prostate cancer	0.00299	0.00707	CbGbCtD
Amitriptyline—CYP2B6—Doxorubicin—prostate cancer	0.00283	0.00669	CbGbCtD
Amitriptyline—ABCB1—Prednisone—prostate cancer	0.0028	0.00662	CbGbCtD
Amitriptyline—CYP1A2—Etoposide—prostate cancer	0.00243	0.00575	CbGbCtD
Amitriptyline—CYP3A4—Conjugated Estrogens—prostate cancer	0.00222	0.00526	CbGbCtD
Amitriptyline—ABCB1—Etoposide—prostate cancer	0.00213	0.00503	CbGbCtD
Amitriptyline—CYP3A4—Mitoxantrone—prostate cancer	0.00202	0.00478	CbGbCtD
Amitriptyline—NTRK2—prostate gland—prostate cancer	0.00196	0.0358	CbGeAlD
Amitriptyline—CYP3A4—Estradiol—prostate cancer	0.00195	0.00461	CbGbCtD
Amitriptyline—ABCB1—Docetaxel—prostate cancer	0.00195	0.0046	CbGbCtD
Amitriptyline—CYP3A4—Prednisone—prostate cancer	0.00168	0.00397	CbGbCtD
Amitriptyline—ABCB1—Doxorubicin—prostate cancer	0.00145	0.00343	CbGbCtD
Amitriptyline—CYP2D6—Doxorubicin—prostate cancer	0.00137	0.00323	CbGbCtD
Amitriptyline—CYP3A4—Etoposide—prostate cancer	0.00127	0.00301	CbGbCtD
Amitriptyline—CYP2C19—urine—prostate cancer	0.00122	0.0222	CbGeAlD
Amitriptyline—CYP3A4—Docetaxel—prostate cancer	0.00117	0.00276	CbGbCtD
Amitriptyline—KCND3—prostate gland—prostate cancer	0.00113	0.0206	CbGeAlD
Amitriptyline—NTRK1—testis—prostate cancer	0.00113	0.0206	CbGeAlD
Amitriptyline—HRH4—bone marrow—prostate cancer	0.00108	0.0197	CbGeAlD
Amitriptyline—NTRK2—bone marrow—prostate cancer	0.00101	0.0184	CbGeAlD
Amitriptyline—CYP1A2—urine—prostate cancer	0.000996	0.0181	CbGeAlD
Amitriptyline—CYP2C9—urine—prostate cancer	0.000945	0.0172	CbGeAlD
Amitriptyline—CYP2E1—urine—prostate cancer	0.000896	0.0163	CbGeAlD
Amitriptyline—OPRK1—prostate gland—prostate cancer	0.000893	0.0163	CbGeAlD
Amitriptyline—CYP3A4—Doxorubicin—prostate cancer	0.000869	0.00205	CbGbCtD
Amitriptyline—NTRK2—testis—prostate cancer	0.000865	0.0158	CbGeAlD
Amitriptyline—HTR2A—urine—prostate cancer	0.000779	0.0142	CbGeAlD
Amitriptyline—ADRA1D—prostate gland—prostate cancer	0.000753	0.0137	CbGeAlD
Amitriptyline—CYP3A4—urine—prostate cancer	0.000721	0.0131	CbGeAlD
Amitriptyline—CYP2D6—urine—prostate cancer	0.000709	0.0129	CbGeAlD
Amitriptyline—SIGMAR1—Levonorgestrel—Ethinyl Estradiol—prostate cancer	0.000669	1	CbGdCrCtD
Amitriptyline—OPRD1—renal system—prostate cancer	0.000635	0.0116	CbGeAlD
Amitriptyline—NTRK2—lymph node—prostate cancer	0.000627	0.0114	CbGeAlD
Amitriptyline—ORM1—prostate gland—prostate cancer	0.00062	0.0113	CbGeAlD
Amitriptyline—CHRM5—epithelium—prostate cancer	0.000619	0.0113	CbGeAlD
Amitriptyline—KCNQ2—testis—prostate cancer	0.000604	0.011	CbGeAlD
Amitriptyline—CHRM2—prostate gland—prostate cancer	0.000578	0.0105	CbGeAlD
Amitriptyline—KCND2—testis—prostate cancer	0.000572	0.0104	CbGeAlD
Amitriptyline—ADRA1D—epithelium—prostate cancer	0.000553	0.0101	CbGeAlD
Amitriptyline—CHRM1—prostate gland—prostate cancer	0.000526	0.00959	CbGeAlD
Amitriptyline—SIGMAR1—prostate gland—prostate cancer	0.000525	0.00956	CbGeAlD
Amitriptyline—ADRA1B—renal system—prostate cancer	0.000525	0.00956	CbGeAlD
Amitriptyline—ADRA1D—urethra—prostate cancer	0.000504	0.00918	CbGeAlD
Amitriptyline—KCND3—testis—prostate cancer	0.000498	0.00908	CbGeAlD
Amitriptyline—CHRM4—testis—prostate cancer	0.000475	0.00865	CbGeAlD
Amitriptyline—CHRM3—prostate gland—prostate cancer	0.000471	0.00858	CbGeAlD
Amitriptyline—SIGMAR1—seminal vesicle—prostate cancer	0.000444	0.00809	CbGeAlD
Amitriptyline—ADRA1A—prostate gland—prostate cancer	0.000432	0.00788	CbGeAlD
Amitriptyline—KCND3—lymph node—prostate cancer	0.000361	0.00658	CbGeAlD
Amitriptyline—SIGMAR1—urethra—prostate cancer	0.000351	0.0064	CbGeAlD
Amitriptyline—CYP3A5—prostate gland—prostate cancer	0.000345	0.00628	CbGeAlD
Amitriptyline—HRH1—prostate gland—prostate cancer	0.000335	0.0061	CbGeAlD
Amitriptyline—Dimetacrine—ACHE—prostate cancer	0.00033	0.12	CrCbGaD
Amitriptyline—HTR7—epithelium—prostate cancer	0.000329	0.006	CbGeAlD
Amitriptyline—ADRA2A—prostate gland—prostate cancer	0.000329	0.00599	CbGeAlD
Amitriptyline—CYP2E1—prostate gland—prostate cancer	0.000322	0.00586	CbGeAlD
Amitriptyline—CHRM3—renal system—prostate cancer	0.000321	0.00585	CbGeAlD
Amitriptyline—HTR1A—renal system—prostate cancer	0.00032	0.00583	CbGeAlD
Amitriptyline—ORM1—bone marrow—prostate cancer	0.000319	0.00582	CbGeAlD
Amitriptyline—ADRA1A—epithelium—prostate cancer	0.000318	0.00579	CbGeAlD
Amitriptyline—CHRM3—urethra—prostate cancer	0.000315	0.00575	CbGeAlD
Amitriptyline—HTR7—renal system—prostate cancer	0.000306	0.00557	CbGeAlD
Amitriptyline—ADRA1A—renal system—prostate cancer	0.000295	0.00537	CbGeAlD
Amitriptyline—HRH2—lymph node—prostate cancer	0.000282	0.00513	CbGeAlD
Amitriptyline—OPRM1—testis—prostate cancer	0.00028	0.0051	CbGeAlD
Amitriptyline—ADRA2A—seminal vesicle—prostate cancer	0.000278	0.00507	CbGeAlD
Amitriptyline—CYP2E1—seminal vesicle—prostate cancer	0.000272	0.00496	CbGeAlD
Amitriptyline—SIGMAR1—bone marrow—prostate cancer	0.00027	0.00493	CbGeAlD
Amitriptyline—CYP2C8—renal system—prostate cancer	0.00026	0.00475	CbGeAlD
Amitriptyline—HRH1—epithelium—prostate cancer	0.000246	0.00448	CbGeAlD
Amitriptyline—CYP1A2—renal system—prostate cancer	0.000244	0.00444	CbGeAlD
Amitriptyline—ALB—testis—prostate cancer	0.000239	0.00436	CbGeAlD
Amitriptyline—CYP3A5—renal system—prostate cancer	0.000235	0.00428	CbGeAlD
Amitriptyline—CYP2B6—renal system—prostate cancer	0.000234	0.00426	CbGeAlD
Amitriptyline—SIGMAR1—testis—prostate cancer	0.000231	0.00421	CbGeAlD
Amitriptyline—HRH1—urethra—prostate cancer	0.000224	0.00408	CbGeAlD
Amitriptyline—ADRA2A—urethra—prostate cancer	0.00022	0.00401	CbGeAlD
Amitriptyline—CYP2E1—renal system—prostate cancer	0.000219	0.00399	CbGeAlD
Amitriptyline—CYP2E1—urethra—prostate cancer	0.000215	0.00392	CbGeAlD
Amitriptyline—CHRM3—testis—prostate cancer	0.000207	0.00378	CbGeAlD
Amitriptyline—HTR2A—epithelium—prostate cancer	0.000205	0.00374	CbGeAlD
Amitriptyline—SLC6A2—testis—prostate cancer	0.000205	0.00373	CbGeAlD
Amitriptyline—ORM1—lymph node—prostate cancer	0.000198	0.00361	CbGeAlD
Amitriptyline—HTR7—testis—prostate cancer	0.000197	0.0036	CbGeAlD
Amitriptyline—HTR2A—renal system—prostate cancer	0.000191	0.00347	CbGeAlD
Amitriptyline—DRD2—testis—prostate cancer	0.000187	0.0034	CbGeAlD
Amitriptyline—ABCB1—prostate gland—prostate cancer	0.000183	0.00334	CbGeAlD
Amitriptyline—CYP3A4—renal system—prostate cancer	0.000176	0.00321	CbGeAlD
Amitriptyline—ALB—lymph node—prostate cancer	0.000174	0.00316	CbGeAlD
Amitriptyline—CYP2D6—renal system—prostate cancer	0.000174	0.00316	CbGeAlD
Amitriptyline—CYP2C8—testis—prostate cancer	0.000168	0.00307	CbGeAlD
Amitriptyline—SIGMAR1—lymph node—prostate cancer	0.000168	0.00305	CbGeAlD
Amitriptyline—ABCB1—seminal vesicle—prostate cancer	0.000155	0.00282	CbGeAlD
Amitriptyline—CYP2B6—testis—prostate cancer	0.000151	0.00275	CbGeAlD
Amitriptyline—SLC6A2—lymph node—prostate cancer	0.000149	0.00271	CbGeAlD
Amitriptyline—HRH1—testis—prostate cancer	0.000147	0.00269	CbGeAlD
Amitriptyline—ADRA2A—testis—prostate cancer	0.000145	0.00264	CbGeAlD
Amitriptyline—CYP2E1—testis—prostate cancer	0.000142	0.00258	CbGeAlD
Amitriptyline—ABCB1—epithelium—prostate cancer	0.000135	0.00245	CbGeAlD
Amitriptyline—Oxcarbazepine—CYP3A5—prostate cancer	0.000126	0.0457	CrCbGaD
Amitriptyline—ABCB1—renal system—prostate cancer	0.000125	0.00228	CbGeAlD
Amitriptyline—HTR2A—testis—prostate cancer	0.000123	0.00224	CbGeAlD
Amitriptyline—ABCB1—urethra—prostate cancer	0.000123	0.00223	CbGeAlD
Amitriptyline—Thiothixene—SLC22A1—prostate cancer	0.000113	0.0411	CrCbGaD
Amitriptyline—CYP2D6—testis—prostate cancer	0.000112	0.00204	CbGeAlD
Amitriptyline—HRH1—lymph node—prostate cancer	0.000107	0.00195	CbGeAlD
Amitriptyline—ADRA2A—lymph node—prostate cancer	0.000105	0.00191	CbGeAlD
Amitriptyline—Azatadine—CYP3A4—prostate cancer	0.000102	0.0371	CrCbGaD
Amitriptyline—Desipramine—SLC22A3—prostate cancer	0.000101	0.0365	CrCbGaD
Amitriptyline—Diphenhydramine—CYP2C18—prostate cancer	9.91e-05	0.036	CrCbGaD
Amitriptyline—Clomipramine—GSTP1—prostate cancer	9.69e-05	0.0352	CrCbGaD
Amitriptyline—ABCB1—bone marrow—prostate cancer	9.44e-05	0.00172	CbGeAlD
Amitriptyline—Desipramine—CYP2C18—prostate cancer	8.83e-05	0.0321	CrCbGaD
Amitriptyline—Oxcarbazepine—CYP2C19—prostate cancer	8.57e-05	0.0311	CrCbGaD
Amitriptyline—Imipramine—SLC22A3—prostate cancer	8.52e-05	0.0309	CrCbGaD
Amitriptyline—Diphenhydramine—SLC22A1—prostate cancer	8.09e-05	0.0294	CrCbGaD
Amitriptyline—ABCB1—testis—prostate cancer	8.07e-05	0.00147	CbGeAlD
Amitriptyline—Imipramine—CYP2C18—prostate cancer	7.49e-05	0.0272	CrCbGaD
Amitriptyline—Desipramine—SLC22A1—prostate cancer	7.21e-05	0.0262	CrCbGaD
Amitriptyline—Olopatadine—CYP3A4—prostate cancer	7.08e-05	0.0257	CrCbGaD
Amitriptyline—Nortriptyline—CYP3A5—prostate cancer	7.06e-05	0.0256	CrCbGaD
Amitriptyline—Alimemazine—CYP3A4—prostate cancer	6.46e-05	0.0235	CrCbGaD
Amitriptyline—Anorexia—Etoposide—prostate cancer	6.3e-05	0.000521	CcSEcCtD
Amitriptyline—Body temperature increased—Mitoxantrone—prostate cancer	6.28e-05	0.00052	CcSEcCtD
Amitriptyline—Pancytopenia—Epirubicin—prostate cancer	6.18e-05	0.000512	CcSEcCtD
Amitriptyline—Hypotension—Etoposide—prostate cancer	6.17e-05	0.000511	CcSEcCtD
Amitriptyline—Vision blurred—Capecitabine—prostate cancer	6.14e-05	0.000508	CcSEcCtD
Amitriptyline—Asthenia—Estradiol—prostate cancer	6.11e-05	0.000506	CcSEcCtD
Amitriptyline—Imipramine—SLC22A1—prostate cancer	6.11e-05	0.0222	CrCbGaD
Amitriptyline—Tremor—Capecitabine—prostate cancer	6.1e-05	0.000505	CcSEcCtD
Amitriptyline—Ill-defined disorder—Capecitabine—prostate cancer	6.04e-05	0.0005	CcSEcCtD
Amitriptyline—Syncope—Docetaxel—prostate cancer	6.03e-05	0.000499	CcSEcCtD
Amitriptyline—Pruritus—Estradiol—prostate cancer	6.03e-05	0.000499	CcSEcCtD
Amitriptyline—Leukopenia—Docetaxel—prostate cancer	6.02e-05	0.000498	CcSEcCtD
Amitriptyline—Pollakiuria—Epirubicin—prostate cancer	6.01e-05	0.000498	CcSEcCtD
Amitriptyline—Eosinophilia—Doxorubicin—prostate cancer	5.96e-05	0.000494	CcSEcCtD
Amitriptyline—Cyclobenzaprine—CYP3A4—prostate cancer	5.96e-05	0.0216	CrCbGaD
Amitriptyline—Arrhythmia—Prednisone—prostate cancer	5.95e-05	0.000493	CcSEcCtD
Amitriptyline—Palpitations—Docetaxel—prostate cancer	5.94e-05	0.000492	CcSEcCtD
Amitriptyline—Paraesthesia—Etoposide—prostate cancer	5.93e-05	0.000491	CcSEcCtD
Amitriptyline—Weight increased—Epirubicin—prostate cancer	5.93e-05	0.00049	CcSEcCtD
Amitriptyline—Epinastine—CYP3A4—prostate cancer	5.91e-05	0.0215	CrCbGaD
Amitriptyline—Loss of consciousness—Docetaxel—prostate cancer	5.91e-05	0.000489	CcSEcCtD
Amitriptyline—Alopecia—Prednisone—prostate cancer	5.89e-05	0.000487	CcSEcCtD
Amitriptyline—Malaise—Capecitabine—prostate cancer	5.87e-05	0.000486	CcSEcCtD
Amitriptyline—Somnolence—Etoposide—prostate cancer	5.87e-05	0.000486	CcSEcCtD
Amitriptyline—ABCB1—lymph node—prostate cancer	5.85e-05	0.00107	CbGeAlD
Amitriptyline—Syncope—Capecitabine—prostate cancer	5.84e-05	0.000483	CcSEcCtD
Amitriptyline—Diarrhoea—Estradiol—prostate cancer	5.83e-05	0.000483	CcSEcCtD
Amitriptyline—Leukopenia—Capecitabine—prostate cancer	5.83e-05	0.000482	CcSEcCtD
Amitriptyline—Convulsion—Docetaxel—prostate cancer	5.83e-05	0.000482	CcSEcCtD
Amitriptyline—Hypertension—Docetaxel—prostate cancer	5.81e-05	0.000481	CcSEcCtD
Amitriptyline—Drowsiness—Epirubicin—prostate cancer	5.81e-05	0.00048	CcSEcCtD
Amitriptyline—Palpitations—Capecitabine—prostate cancer	5.75e-05	0.000476	CcSEcCtD
Amitriptyline—Decreased appetite—Etoposide—prostate cancer	5.74e-05	0.000475	CcSEcCtD
Amitriptyline—Loss of consciousness—Capecitabine—prostate cancer	5.72e-05	0.000474	CcSEcCtD
Amitriptyline—Pancytopenia—Doxorubicin—prostate cancer	5.72e-05	0.000474	CcSEcCtD
Amitriptyline—Asthenia—Mitoxantrone—prostate cancer	5.7e-05	0.000472	CcSEcCtD
Amitriptyline—Fatigue—Etoposide—prostate cancer	5.69e-05	0.000471	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Epirubicin—prostate cancer	5.69e-05	0.000471	CcSEcCtD
Amitriptyline—Jaundice—Epirubicin—prostate cancer	5.66e-05	0.000468	CcSEcCtD
Amitriptyline—Stomatitis—Epirubicin—prostate cancer	5.66e-05	0.000468	CcSEcCtD
Amitriptyline—Constipation—Etoposide—prostate cancer	5.65e-05	0.000467	CcSEcCtD
Amitriptyline—Dizziness—Estradiol—prostate cancer	5.64e-05	0.000466	CcSEcCtD
Amitriptyline—Desipramine—CYP2A6—prostate cancer	5.63e-05	0.0204	CrCbGaD
Amitriptyline—Hypertension—Capecitabine—prostate cancer	5.62e-05	0.000465	CcSEcCtD
Amitriptyline—Dry mouth—Docetaxel—prostate cancer	5.6e-05	0.000464	CcSEcCtD
Amitriptyline—Pollakiuria—Doxorubicin—prostate cancer	5.57e-05	0.000461	CcSEcCtD
Amitriptyline—Confusional state—Docetaxel—prostate cancer	5.54e-05	0.000458	CcSEcCtD
Amitriptyline—Anxiety—Capecitabine—prostate cancer	5.53e-05	0.000457	CcSEcCtD
Amitriptyline—Oedema—Docetaxel—prostate cancer	5.49e-05	0.000454	CcSEcCtD
Amitriptyline—Weight increased—Doxorubicin—prostate cancer	5.48e-05	0.000454	CcSEcCtD
Amitriptyline—Discomfort—Capecitabine—prostate cancer	5.48e-05	0.000453	CcSEcCtD
Amitriptyline—Vision blurred—Prednisone—prostate cancer	5.47e-05	0.000452	CcSEcCtD
Amitriptyline—Oxcarbazepine—CYP3A4—prostate cancer	5.45e-05	0.0198	CrCbGaD
Amitriptyline—Feeling abnormal—Etoposide—prostate cancer	5.44e-05	0.00045	CcSEcCtD
Amitriptyline—Diarrhoea—Mitoxantrone—prostate cancer	5.43e-05	0.00045	CcSEcCtD
Amitriptyline—Dry mouth—Capecitabine—prostate cancer	5.42e-05	0.000449	CcSEcCtD
Amitriptyline—Vomiting—Estradiol—prostate cancer	5.42e-05	0.000448	CcSEcCtD
Amitriptyline—Agranulocytosis—Epirubicin—prostate cancer	5.42e-05	0.000448	CcSEcCtD
Amitriptyline—Shock—Docetaxel—prostate cancer	5.4e-05	0.000447	CcSEcCtD
Amitriptyline—Ill-defined disorder—Prednisone—prostate cancer	5.38e-05	0.000445	CcSEcCtD
Amitriptyline—Thrombocytopenia—Docetaxel—prostate cancer	5.37e-05	0.000445	CcSEcCtD
Amitriptyline—Rash—Estradiol—prostate cancer	5.37e-05	0.000445	CcSEcCtD
Amitriptyline—Drowsiness—Doxorubicin—prostate cancer	5.37e-05	0.000445	CcSEcCtD
Amitriptyline—Dermatitis—Estradiol—prostate cancer	5.37e-05	0.000444	CcSEcCtD
Amitriptyline—Confusional state—Capecitabine—prostate cancer	5.36e-05	0.000444	CcSEcCtD
Amitriptyline—Tachycardia—Docetaxel—prostate cancer	5.36e-05	0.000443	CcSEcCtD
Amitriptyline—Headache—Estradiol—prostate cancer	5.34e-05	0.000442	CcSEcCtD
Amitriptyline—Agitation—Prednisone—prostate cancer	5.33e-05	0.000441	CcSEcCtD
Amitriptyline—Oedema—Capecitabine—prostate cancer	5.31e-05	0.00044	CcSEcCtD
Amitriptyline—Neuropathy peripheral—Doxorubicin—prostate cancer	5.27e-05	0.000436	CcSEcCtD
Amitriptyline—Urticaria—Etoposide—prostate cancer	5.25e-05	0.000434	CcSEcCtD
Amitriptyline—Jaundice—Doxorubicin—prostate cancer	5.24e-05	0.000433	CcSEcCtD
Amitriptyline—Stomatitis—Doxorubicin—prostate cancer	5.24e-05	0.000433	CcSEcCtD
Amitriptyline—Anorexia—Docetaxel—prostate cancer	5.23e-05	0.000433	CcSEcCtD
Amitriptyline—Malaise—Prednisone—prostate cancer	5.23e-05	0.000433	CcSEcCtD
Amitriptyline—Shock—Capecitabine—prostate cancer	5.23e-05	0.000433	CcSEcCtD
Amitriptyline—Body temperature increased—Etoposide—prostate cancer	5.22e-05	0.000432	CcSEcCtD
Amitriptyline—Hepatitis—Epirubicin—prostate cancer	5.21e-05	0.000431	CcSEcCtD
Amitriptyline—Thrombocytopenia—Capecitabine—prostate cancer	5.2e-05	0.000431	CcSEcCtD
Amitriptyline—Syncope—Prednisone—prostate cancer	5.2e-05	0.000431	CcSEcCtD
Amitriptyline—Tachycardia—Capecitabine—prostate cancer	5.19e-05	0.000429	CcSEcCtD
Amitriptyline—Hypoaesthesia—Epirubicin—prostate cancer	5.19e-05	0.000429	CcSEcCtD
Amitriptyline—Hyperhidrosis—Capecitabine—prostate cancer	5.14e-05	0.000425	CcSEcCtD
Amitriptyline—Hypotension—Docetaxel—prostate cancer	5.13e-05	0.000425	CcSEcCtD
Amitriptyline—Loss of consciousness—Prednisone—prostate cancer	5.1e-05	0.000422	CcSEcCtD
Amitriptyline—Anorexia—Capecitabine—prostate cancer	5.07e-05	0.000419	CcSEcCtD
Amitriptyline—Nausea—Estradiol—prostate cancer	5.06e-05	0.000419	CcSEcCtD
Amitriptyline—Vomiting—Mitoxantrone—prostate cancer	5.05e-05	0.000418	CcSEcCtD
Amitriptyline—Convulsion—Prednisone—prostate cancer	5.03e-05	0.000416	CcSEcCtD
Amitriptyline—Agranulocytosis—Doxorubicin—prostate cancer	5.01e-05	0.000415	CcSEcCtD
Amitriptyline—Hypertension—Prednisone—prostate cancer	5.01e-05	0.000414	CcSEcCtD
Amitriptyline—Rash—Mitoxantrone—prostate cancer	5.01e-05	0.000414	CcSEcCtD
Amitriptyline—Dermatitis—Mitoxantrone—prostate cancer	5e-05	0.000414	CcSEcCtD
Amitriptyline—Headache—Mitoxantrone—prostate cancer	4.97e-05	0.000412	CcSEcCtD
Amitriptyline—Hypotension—Capecitabine—prostate cancer	4.97e-05	0.000411	CcSEcCtD
Amitriptyline—Insomnia—Docetaxel—prostate cancer	4.96e-05	0.000411	CcSEcCtD
Amitriptyline—Paraesthesia—Docetaxel—prostate cancer	4.93e-05	0.000408	CcSEcCtD
Amitriptyline—Anxiety—Prednisone—prostate cancer	4.92e-05	0.000407	CcSEcCtD
Amitriptyline—Clomipramine—CYP2C19—prostate cancer	4.92e-05	0.0179	CrCbGaD
Amitriptyline—Somnolence—Docetaxel—prostate cancer	4.88e-05	0.000404	CcSEcCtD
Amitriptyline—Discomfort—Prednisone—prostate cancer	4.88e-05	0.000404	CcSEcCtD
Amitriptyline—Tinnitus—Epirubicin—prostate cancer	4.86e-05	0.000402	CcSEcCtD
Amitriptyline—Nortriptyline—CYP2E1—prostate cancer	4.85e-05	0.0176	CrCbGaD
Amitriptyline—Dyspepsia—Docetaxel—prostate cancer	4.83e-05	0.0004	CcSEcCtD
Amitriptyline—Hepatitis—Doxorubicin—prostate cancer	4.82e-05	0.000399	CcSEcCtD
Amitriptyline—Nortriptyline—CYP2C19—prostate cancer	4.81e-05	0.0175	CrCbGaD
Amitriptyline—Insomnia—Capecitabine—prostate cancer	4.81e-05	0.000398	CcSEcCtD
Amitriptyline—Hypoaesthesia—Doxorubicin—prostate cancer	4.8e-05	0.000397	CcSEcCtD
Amitriptyline—Paraesthesia—Capecitabine—prostate cancer	4.77e-05	0.000395	CcSEcCtD
Amitriptyline—Decreased appetite—Docetaxel—prostate cancer	4.77e-05	0.000395	CcSEcCtD
Amitriptyline—Asthenia—Etoposide—prostate cancer	4.74e-05	0.000392	CcSEcCtD
Amitriptyline—Oedema—Prednisone—prostate cancer	4.73e-05	0.000392	CcSEcCtD
Amitriptyline—Fatigue—Docetaxel—prostate cancer	4.73e-05	0.000392	CcSEcCtD
Amitriptyline—Nausea—Mitoxantrone—prostate cancer	4.72e-05	0.00039	CcSEcCtD
Amitriptyline—Constipation—Docetaxel—prostate cancer	4.69e-05	0.000389	CcSEcCtD
Amitriptyline—Dyspepsia—Capecitabine—prostate cancer	4.68e-05	0.000387	CcSEcCtD
Amitriptyline—Pruritus—Etoposide—prostate cancer	4.67e-05	0.000387	CcSEcCtD
Amitriptyline—Shock—Prednisone—prostate cancer	4.66e-05	0.000385	CcSEcCtD
Amitriptyline—Arrhythmia—Epirubicin—prostate cancer	4.66e-05	0.000385	CcSEcCtD
Amitriptyline—Tachycardia—Prednisone—prostate cancer	4.62e-05	0.000382	CcSEcCtD
Amitriptyline—Decreased appetite—Capecitabine—prostate cancer	4.62e-05	0.000382	CcSEcCtD
Amitriptyline—Alopecia—Epirubicin—prostate cancer	4.61e-05	0.000381	CcSEcCtD
Amitriptyline—Desipramine—ADRB2—prostate cancer	4.6e-05	0.0167	CrCbGaD
Amitriptyline—Fatigue—Capecitabine—prostate cancer	4.58e-05	0.000379	CcSEcCtD
Amitriptyline—Hyperhidrosis—Prednisone—prostate cancer	4.58e-05	0.000379	CcSEcCtD
Amitriptyline—Constipation—Capecitabine—prostate cancer	4.54e-05	0.000376	CcSEcCtD
Amitriptyline—Trimipramine—CYP2C19—prostate cancer	4.53e-05	0.0164	CrCbGaD
Amitriptyline—Feeling abnormal—Docetaxel—prostate cancer	4.52e-05	0.000374	CcSEcCtD
Amitriptyline—Diarrhoea—Etoposide—prostate cancer	4.52e-05	0.000374	CcSEcCtD
Amitriptyline—Anorexia—Prednisone—prostate cancer	4.51e-05	0.000373	CcSEcCtD
Amitriptyline—Tinnitus—Doxorubicin—prostate cancer	4.5e-05	0.000372	CcSEcCtD
Amitriptyline—Diphenhydramine—CYP2C19—prostate cancer	4.45e-05	0.0161	CrCbGaD
Amitriptyline—Dysgeusia—Epirubicin—prostate cancer	4.44e-05	0.000368	CcSEcCtD
Amitriptyline—Feeling abnormal—Capecitabine—prostate cancer	4.38e-05	0.000362	CcSEcCtD
Amitriptyline—Dizziness—Etoposide—prostate cancer	4.37e-05	0.000362	CcSEcCtD
Amitriptyline—Body temperature increased—Docetaxel—prostate cancer	4.34e-05	0.000359	CcSEcCtD
Amitriptyline—Doxepin—CYP2C19—prostate cancer	4.31e-05	0.0157	CrCbGaD
Amitriptyline—Arrhythmia—Doxorubicin—prostate cancer	4.31e-05	0.000357	CcSEcCtD
Amitriptyline—Insomnia—Prednisone—prostate cancer	4.28e-05	0.000354	CcSEcCtD
Amitriptyline—Vision blurred—Epirubicin—prostate cancer	4.28e-05	0.000354	CcSEcCtD
Amitriptyline—Alopecia—Doxorubicin—prostate cancer	4.26e-05	0.000353	CcSEcCtD
Amitriptyline—Paraesthesia—Prednisone—prostate cancer	4.25e-05	0.000352	CcSEcCtD
Amitriptyline—Orphenadrine—CYP2E1—prostate cancer	4.25e-05	0.0154	CrCbGaD
Amitriptyline—Urticaria—Capecitabine—prostate cancer	4.22e-05	0.000349	CcSEcCtD
Amitriptyline—Ill-defined disorder—Epirubicin—prostate cancer	4.21e-05	0.000348	CcSEcCtD
Amitriptyline—Body temperature increased—Capecitabine—prostate cancer	4.2e-05	0.000348	CcSEcCtD
Amitriptyline—Vomiting—Etoposide—prostate cancer	4.2e-05	0.000348	CcSEcCtD
Amitriptyline—Agitation—Epirubicin—prostate cancer	4.17e-05	0.000345	CcSEcCtD
Amitriptyline—Dyspepsia—Prednisone—prostate cancer	4.17e-05	0.000345	CcSEcCtD
Amitriptyline—Rash—Etoposide—prostate cancer	4.16e-05	0.000345	CcSEcCtD
Amitriptyline—Dermatitis—Etoposide—prostate cancer	4.16e-05	0.000344	CcSEcCtD
Amitriptyline—Headache—Etoposide—prostate cancer	4.14e-05	0.000342	CcSEcCtD
Amitriptyline—Decreased appetite—Prednisone—prostate cancer	4.12e-05	0.000341	CcSEcCtD
Amitriptyline—Dysgeusia—Doxorubicin—prostate cancer	4.11e-05	0.00034	CcSEcCtD
Amitriptyline—Malaise—Epirubicin—prostate cancer	4.09e-05	0.000339	CcSEcCtD
Amitriptyline—Fatigue—Prednisone—prostate cancer	4.08e-05	0.000338	CcSEcCtD
Amitriptyline—Syncope—Epirubicin—prostate cancer	4.07e-05	0.000337	CcSEcCtD
Amitriptyline—Leukopenia—Epirubicin—prostate cancer	4.06e-05	0.000336	CcSEcCtD
Amitriptyline—Constipation—Prednisone—prostate cancer	4.05e-05	0.000335	CcSEcCtD
Amitriptyline—Palpitations—Epirubicin—prostate cancer	4.01e-05	0.000332	CcSEcCtD
Amitriptyline—Desipramine—CYP2E1—prostate cancer	4e-05	0.0145	CrCbGaD
Amitriptyline—Loss of consciousness—Epirubicin—prostate cancer	3.99e-05	0.00033	CcSEcCtD
Amitriptyline—Desipramine—CYP2C19—prostate cancer	3.96e-05	0.0144	CrCbGaD
Amitriptyline—Vision blurred—Doxorubicin—prostate cancer	3.96e-05	0.000327	CcSEcCtD
Amitriptyline—Asthenia—Docetaxel—prostate cancer	3.94e-05	0.000326	CcSEcCtD
Amitriptyline—Convulsion—Epirubicin—prostate cancer	3.93e-05	0.000325	CcSEcCtD
Amitriptyline—Nausea—Etoposide—prostate cancer	3.92e-05	0.000325	CcSEcCtD
Amitriptyline—Hypertension—Epirubicin—prostate cancer	3.92e-05	0.000324	CcSEcCtD
Amitriptyline—Feeling abnormal—Prednisone—prostate cancer	3.9e-05	0.000323	CcSEcCtD
Amitriptyline—Ill-defined disorder—Doxorubicin—prostate cancer	3.89e-05	0.000322	CcSEcCtD
Amitriptyline—Pruritus—Docetaxel—prostate cancer	3.88e-05	0.000321	CcSEcCtD
Amitriptyline—Agitation—Doxorubicin—prostate cancer	3.86e-05	0.000319	CcSEcCtD
Amitriptyline—Anxiety—Epirubicin—prostate cancer	3.85e-05	0.000319	CcSEcCtD
Amitriptyline—Promazine—CYP2C19—prostate cancer	3.83e-05	0.0139	CrCbGaD
Amitriptyline—Discomfort—Epirubicin—prostate cancer	3.82e-05	0.000316	CcSEcCtD
Amitriptyline—Asthenia—Capecitabine—prostate cancer	3.81e-05	0.000316	CcSEcCtD
Amitriptyline—Malaise—Doxorubicin—prostate cancer	3.79e-05	0.000313	CcSEcCtD
Amitriptyline—Dry mouth—Epirubicin—prostate cancer	3.78e-05	0.000313	CcSEcCtD
Amitriptyline—Syncope—Doxorubicin—prostate cancer	3.76e-05	0.000312	CcSEcCtD
Amitriptyline—Urticaria—Prednisone—prostate cancer	3.76e-05	0.000311	CcSEcCtD
Amitriptyline—Pruritus—Capecitabine—prostate cancer	3.76e-05	0.000311	CcSEcCtD
Amitriptyline—Leukopenia—Doxorubicin—prostate cancer	3.76e-05	0.000311	CcSEcCtD
Amitriptyline—Diarrhoea—Docetaxel—prostate cancer	3.76e-05	0.000311	CcSEcCtD
Amitriptyline—Body temperature increased—Prednisone—prostate cancer	3.74e-05	0.00031	CcSEcCtD
Amitriptyline—Confusional state—Epirubicin—prostate cancer	3.73e-05	0.000309	CcSEcCtD
Amitriptyline—Palpitations—Doxorubicin—prostate cancer	3.71e-05	0.000307	CcSEcCtD
Amitriptyline—Oedema—Epirubicin—prostate cancer	3.7e-05	0.000306	CcSEcCtD
Amitriptyline—Loss of consciousness—Doxorubicin—prostate cancer	3.69e-05	0.000305	CcSEcCtD
Amitriptyline—Shock—Epirubicin—prostate cancer	3.64e-05	0.000301	CcSEcCtD
Amitriptyline—Convulsion—Doxorubicin—prostate cancer	3.64e-05	0.000301	CcSEcCtD
Amitriptyline—Diarrhoea—Capecitabine—prostate cancer	3.64e-05	0.000301	CcSEcCtD
Amitriptyline—Dizziness—Docetaxel—prostate cancer	3.63e-05	0.0003	CcSEcCtD
Amitriptyline—Thrombocytopenia—Epirubicin—prostate cancer	3.63e-05	0.0003	CcSEcCtD
Amitriptyline—Hypertension—Doxorubicin—prostate cancer	3.62e-05	0.0003	CcSEcCtD
Amitriptyline—Tachycardia—Epirubicin—prostate cancer	3.61e-05	0.000299	CcSEcCtD
Amitriptyline—Hyperhidrosis—Epirubicin—prostate cancer	3.58e-05	0.000296	CcSEcCtD
Amitriptyline—Anxiety—Doxorubicin—prostate cancer	3.56e-05	0.000295	CcSEcCtD
Amitriptyline—Discomfort—Doxorubicin—prostate cancer	3.53e-05	0.000292	CcSEcCtD
Amitriptyline—Anorexia—Epirubicin—prostate cancer	3.53e-05	0.000292	CcSEcCtD
Amitriptyline—Dizziness—Capecitabine—prostate cancer	3.51e-05	0.000291	CcSEcCtD
Amitriptyline—Dry mouth—Doxorubicin—prostate cancer	3.5e-05	0.000289	CcSEcCtD
Amitriptyline—Vomiting—Docetaxel—prostate cancer	3.49e-05	0.000289	CcSEcCtD
Amitriptyline—Rash—Docetaxel—prostate cancer	3.46e-05	0.000286	CcSEcCtD
Amitriptyline—Hypotension—Epirubicin—prostate cancer	3.46e-05	0.000286	CcSEcCtD
Amitriptyline—Dermatitis—Docetaxel—prostate cancer	3.46e-05	0.000286	CcSEcCtD
Amitriptyline—Confusional state—Doxorubicin—prostate cancer	3.45e-05	0.000286	CcSEcCtD
Amitriptyline—Headache—Docetaxel—prostate cancer	3.44e-05	0.000285	CcSEcCtD
Amitriptyline—Oedema—Doxorubicin—prostate cancer	3.43e-05	0.000284	CcSEcCtD
Amitriptyline—Mianserin—CYP3A4—prostate cancer	3.42e-05	0.0124	CrCbGaD
Amitriptyline—Asthenia—Prednisone—prostate cancer	3.4e-05	0.000281	CcSEcCtD
Amitriptyline—Imipramine—CYP2E1—prostate cancer	3.39e-05	0.0123	CrCbGaD
Amitriptyline—Vomiting—Capecitabine—prostate cancer	3.38e-05	0.00028	CcSEcCtD
Amitriptyline—Shock—Doxorubicin—prostate cancer	3.37e-05	0.000279	CcSEcCtD
Amitriptyline—Imipramine—CYP2C19—prostate cancer	3.36e-05	0.0122	CrCbGaD
Amitriptyline—Thrombocytopenia—Doxorubicin—prostate cancer	3.35e-05	0.000278	CcSEcCtD
Amitriptyline—Rash—Capecitabine—prostate cancer	3.35e-05	0.000277	CcSEcCtD
Amitriptyline—Pruritus—Prednisone—prostate cancer	3.35e-05	0.000277	CcSEcCtD
Amitriptyline—Insomnia—Epirubicin—prostate cancer	3.35e-05	0.000277	CcSEcCtD
Amitriptyline—Dermatitis—Capecitabine—prostate cancer	3.35e-05	0.000277	CcSEcCtD
Amitriptyline—Tachycardia—Doxorubicin—prostate cancer	3.34e-05	0.000277	CcSEcCtD
Amitriptyline—Headache—Capecitabine—prostate cancer	3.33e-05	0.000276	CcSEcCtD
Amitriptyline—Paraesthesia—Epirubicin—prostate cancer	3.32e-05	0.000275	CcSEcCtD
Amitriptyline—Hyperhidrosis—Doxorubicin—prostate cancer	3.31e-05	0.000274	CcSEcCtD
Amitriptyline—Somnolence—Epirubicin—prostate cancer	3.29e-05	0.000272	CcSEcCtD
Amitriptyline—Anorexia—Doxorubicin—prostate cancer	3.27e-05	0.00027	CcSEcCtD
Amitriptyline—Nausea—Docetaxel—prostate cancer	3.26e-05	0.00027	CcSEcCtD
Amitriptyline—Dyspepsia—Epirubicin—prostate cancer	3.26e-05	0.00027	CcSEcCtD
Amitriptyline—Diarrhoea—Prednisone—prostate cancer	3.24e-05	0.000268	CcSEcCtD
Amitriptyline—Decreased appetite—Epirubicin—prostate cancer	3.22e-05	0.000266	CcSEcCtD
Amitriptyline—Hypotension—Doxorubicin—prostate cancer	3.2e-05	0.000265	CcSEcCtD
Amitriptyline—Fatigue—Epirubicin—prostate cancer	3.19e-05	0.000264	CcSEcCtD
Amitriptyline—Constipation—Epirubicin—prostate cancer	3.17e-05	0.000262	CcSEcCtD
Amitriptyline—Nausea—Capecitabine—prostate cancer	3.16e-05	0.000261	CcSEcCtD
Amitriptyline—Dizziness—Prednisone—prostate cancer	3.13e-05	0.000259	CcSEcCtD
Amitriptyline—Clomipramine—CYP3A4—prostate cancer	3.13e-05	0.0114	CrCbGaD
Amitriptyline—Insomnia—Doxorubicin—prostate cancer	3.1e-05	0.000256	CcSEcCtD
Amitriptyline—Paraesthesia—Doxorubicin—prostate cancer	3.08e-05	0.000255	CcSEcCtD
Amitriptyline—Nortriptyline—CYP3A4—prostate cancer	3.06e-05	0.0111	CrCbGaD
Amitriptyline—Feeling abnormal—Epirubicin—prostate cancer	3.05e-05	0.000253	CcSEcCtD
Amitriptyline—Somnolence—Doxorubicin—prostate cancer	3.05e-05	0.000252	CcSEcCtD
Amitriptyline—Dyspepsia—Doxorubicin—prostate cancer	3.02e-05	0.00025	CcSEcCtD
Amitriptyline—Vomiting—Prednisone—prostate cancer	3.01e-05	0.000249	CcSEcCtD
Amitriptyline—Rash—Prednisone—prostate cancer	2.98e-05	0.000247	CcSEcCtD
Amitriptyline—Dermatitis—Prednisone—prostate cancer	2.98e-05	0.000247	CcSEcCtD
Amitriptyline—Decreased appetite—Doxorubicin—prostate cancer	2.98e-05	0.000246	CcSEcCtD
Amitriptyline—Headache—Prednisone—prostate cancer	2.97e-05	0.000245	CcSEcCtD
Amitriptyline—Fatigue—Doxorubicin—prostate cancer	2.95e-05	0.000244	CcSEcCtD
Amitriptyline—Urticaria—Epirubicin—prostate cancer	2.94e-05	0.000243	CcSEcCtD
Amitriptyline—Constipation—Doxorubicin—prostate cancer	2.93e-05	0.000242	CcSEcCtD
Amitriptyline—Body temperature increased—Epirubicin—prostate cancer	2.93e-05	0.000242	CcSEcCtD
Amitriptyline—Trimipramine—CYP3A4—prostate cancer	2.88e-05	0.0105	CrCbGaD
Amitriptyline—Feeling abnormal—Doxorubicin—prostate cancer	2.82e-05	0.000234	CcSEcCtD
Amitriptyline—Nausea—Prednisone—prostate cancer	2.81e-05	0.000233	CcSEcCtD
Amitriptyline—Doxepin—CYP3A4—prostate cancer	2.74e-05	0.00996	CrCbGaD
Amitriptyline—Urticaria—Doxorubicin—prostate cancer	2.72e-05	0.000225	CcSEcCtD
Amitriptyline—Body temperature increased—Doxorubicin—prostate cancer	2.71e-05	0.000224	CcSEcCtD
Amitriptyline—Orphenadrine—CYP3A4—prostate cancer	2.67e-05	0.00971	CrCbGaD
Amitriptyline—Asthenia—Epirubicin—prostate cancer	2.66e-05	0.00022	CcSEcCtD
Amitriptyline—Pruritus—Epirubicin—prostate cancer	2.62e-05	0.000217	CcSEcCtD
Amitriptyline—Diarrhoea—Epirubicin—prostate cancer	2.53e-05	0.00021	CcSEcCtD
Amitriptyline—Desipramine—CYP3A4—prostate cancer	2.52e-05	0.00914	CrCbGaD
Amitriptyline—Asthenia—Doxorubicin—prostate cancer	2.46e-05	0.000203	CcSEcCtD
Amitriptyline—Dizziness—Epirubicin—prostate cancer	2.45e-05	0.000203	CcSEcCtD
Amitriptyline—Promazine—CYP3A4—prostate cancer	2.44e-05	0.00885	CrCbGaD
Amitriptyline—Pruritus—Doxorubicin—prostate cancer	2.42e-05	0.000201	CcSEcCtD
Amitriptyline—Vomiting—Epirubicin—prostate cancer	2.35e-05	0.000195	CcSEcCtD
Amitriptyline—Diarrhoea—Doxorubicin—prostate cancer	2.34e-05	0.000194	CcSEcCtD
Amitriptyline—Rash—Epirubicin—prostate cancer	2.33e-05	0.000193	CcSEcCtD
Amitriptyline—Dermatitis—Epirubicin—prostate cancer	2.33e-05	0.000193	CcSEcCtD
Amitriptyline—Headache—Epirubicin—prostate cancer	2.32e-05	0.000192	CcSEcCtD
Amitriptyline—Dizziness—Doxorubicin—prostate cancer	2.27e-05	0.000188	CcSEcCtD
Amitriptyline—Nausea—Epirubicin—prostate cancer	2.2e-05	0.000182	CcSEcCtD
Amitriptyline—Vomiting—Doxorubicin—prostate cancer	2.18e-05	0.00018	CcSEcCtD
Amitriptyline—Rash—Doxorubicin—prostate cancer	2.16e-05	0.000179	CcSEcCtD
Amitriptyline—Dermatitis—Doxorubicin—prostate cancer	2.16e-05	0.000179	CcSEcCtD
Amitriptyline—Headache—Doxorubicin—prostate cancer	2.15e-05	0.000178	CcSEcCtD
Amitriptyline—Imipramine—CYP3A4—prostate cancer	2.13e-05	0.00775	CrCbGaD
Amitriptyline—Nausea—Doxorubicin—prostate cancer	2.03e-05	0.000168	CcSEcCtD
Amitriptyline—ALB—Metabolism—PTGS2—prostate cancer	6.03e-07	4.98e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—CREBBP—prostate cancer	6.03e-07	4.98e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—CDKN1A—prostate cancer	6.03e-07	4.98e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PTEN—prostate cancer	6.01e-07	4.97e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—CDKN1A—prostate cancer	6.01e-07	4.97e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PTEN—prostate cancer	5.99e-07	4.96e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—GPCR downstream signaling—AKT1—prostate cancer	5.98e-07	4.95e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—IL6—prostate cancer	5.98e-07	4.95e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—IL6—prostate cancer	5.97e-07	4.94e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling by GPCR—AKT1—prostate cancer	5.97e-07	4.94e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling by GPCR—AKT1—prostate cancer	5.96e-07	4.93e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—EP300—prostate cancer	5.96e-07	4.93e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling by GPCR—AKT1—prostate cancer	5.94e-07	4.91e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—IL6—prostate cancer	5.94e-07	4.91e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EP300—prostate cancer	5.93e-07	4.91e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CASP3—prostate cancer	5.93e-07	4.9e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling by GPCR—AKT1—prostate cancer	5.92e-07	4.9e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL2—prostate cancer	5.92e-07	4.9e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—NOS3—prostate cancer	5.92e-07	4.89e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—TP53—prostate cancer	5.9e-07	4.88e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—IL6—prostate cancer	5.89e-07	4.87e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—MYC—prostate cancer	5.89e-07	4.87e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TGFB1—prostate cancer	5.88e-07	4.86e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling by GPCR—AKT1—prostate cancer	5.86e-07	4.85e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—MYC—prostate cancer	5.86e-07	4.85e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling by GPCR—AKT1—prostate cancer	5.85e-07	4.84e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TGFB1—prostate cancer	5.85e-07	4.83e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—TYMS—prostate cancer	5.84e-07	4.83e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EP300—prostate cancer	5.84e-07	4.83e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—EP300—prostate cancer	5.83e-07	4.82e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EP300—prostate cancer	5.83e-07	4.82e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	5.83e-07	4.82e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—EP300—prostate cancer	5.82e-07	4.81e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—IL6—prostate cancer	5.81e-07	4.81e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EP300—prostate cancer	5.81e-07	4.8e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—PIK3CA—prostate cancer	5.79e-07	4.79e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EP300—prostate cancer	5.79e-07	4.79e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—NOS3—prostate cancer	5.78e-07	4.78e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—GSTM1—prostate cancer	5.77e-07	4.77e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CCND1—prostate cancer	5.77e-07	4.77e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—SRC—prostate cancer	5.77e-07	4.77e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CD—prostate cancer	5.76e-07	4.77e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—EGFR—prostate cancer	5.76e-07	4.76e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—PIK3CA—prostate cancer	5.74e-07	4.74e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—PIK3CA—prostate cancer	5.74e-07	4.74e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EP300—prostate cancer	5.73e-07	4.74e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—EGFR—prostate cancer	5.73e-07	4.74e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EP300—prostate cancer	5.72e-07	4.73e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CTNNB1—prostate cancer	5.71e-07	4.73e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CD—prostate cancer	5.71e-07	4.72e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—SRC—prostate cancer	5.68e-07	4.7e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—LPL—prostate cancer	5.67e-07	4.69e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—SRC—prostate cancer	5.67e-07	4.69e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—SRC—prostate cancer	5.65e-07	4.67e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—IL6—prostate cancer	5.64e-07	4.67e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—SRC—prostate cancer	5.63e-07	4.66e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—VEGFA—prostate cancer	5.62e-07	4.65e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—MYC—prostate cancer	5.61e-07	4.64e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—TP53—prostate cancer	5.6e-07	4.63e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MMP9—prostate cancer	5.6e-07	4.63e-06	CbGpPWpGaD
Amitriptyline—OPRK1—Signaling Pathways—AKT1—prostate cancer	5.6e-07	4.63e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TGFB1—prostate cancer	5.6e-07	4.63e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—CDKN1A—prostate cancer	5.58e-07	4.62e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—SRC—prostate cancer	5.57e-07	4.61e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PTEN—prostate cancer	5.57e-07	4.61e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—STAT3—prostate cancer	5.56e-07	4.6e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—SRC—prostate cancer	5.56e-07	4.6e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CG—prostate cancer	5.55e-07	4.59e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—TP53—prostate cancer	5.55e-07	4.59e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—TP53—prostate cancer	5.55e-07	4.59e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—VEGFA—prostate cancer	5.53e-07	4.57e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—VEGFA—prostate cancer	5.52e-07	4.56e-06	CbGpPWpGaD
Amitriptyline—HTR6—Signaling Pathways—AKT1—prostate cancer	5.52e-07	4.56e-06	CbGpPWpGaD
Amitriptyline—HTR7—Signaling Pathways—AKT1—prostate cancer	5.51e-07	4.56e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—VEGFA—prostate cancer	5.5e-07	4.55e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—EGFR—prostate cancer	5.49e-07	4.54e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—VEGFA—prostate cancer	5.48e-07	4.53e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—STAT3—prostate cancer	5.48e-07	4.53e-06	CbGpPWpGaD
Amitriptyline—HTR1D—Signaling Pathways—AKT1—prostate cancer	5.48e-07	4.53e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CYP1A1—prostate cancer	5.47e-07	4.53e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—STAT3—prostate cancer	5.46e-07	4.52e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CB—prostate cancer	5.46e-07	4.52e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—STAT3—prostate cancer	5.45e-07	4.5e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—NOS3—prostate cancer	5.44e-07	4.5e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—KRAS—prostate cancer	5.44e-07	4.5e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling by GPCR—AKT1—prostate cancer	5.43e-07	4.49e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—VEGFA—prostate cancer	5.43e-07	4.49e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—STAT3—prostate cancer	5.43e-07	4.49e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—ERCC2—prostate cancer	5.43e-07	4.49e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—VEGFA—prostate cancer	5.41e-07	4.48e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—KRAS—prostate cancer	5.41e-07	4.48e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTGS2—prostate cancer	5.41e-07	4.47e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—IL6—prostate cancer	5.4e-07	4.47e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—NOS3—prostate cancer	5.4e-07	4.46e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—STAT3—prostate cancer	5.38e-07	4.45e-06	CbGpPWpGaD
Amitriptyline—HTR1B—Signaling Pathways—AKT1—prostate cancer	5.36e-07	4.43e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—STAT3—prostate cancer	5.36e-07	4.43e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CB—prostate cancer	5.33e-07	4.41e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EP300—prostate cancer	5.31e-07	4.39e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PTEN—prostate cancer	5.29e-07	4.37e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTGS2—prostate cancer	5.28e-07	4.37e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PTEN—prostate cancer	5.26e-07	4.35e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—INS—prostate cancer	5.26e-07	4.35e-06	CbGpPWpGaD
Amitriptyline—CHRM4—Signaling Pathways—AKT1—prostate cancer	5.2e-07	4.3e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—KRAS—prostate cancer	5.18e-07	4.29e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—MYC—prostate cancer	5.17e-07	4.28e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—SRC—prostate cancer	5.17e-07	4.27e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TGFB1—prostate cancer	5.16e-07	4.27e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—CREBBP—prostate cancer	5.15e-07	4.26e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—IL6—prostate cancer	5.13e-07	4.24e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—PIK3CA—prostate cancer	5.12e-07	4.24e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—MTHFR—prostate cancer	5.1e-07	4.22e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—MYC—prostate cancer	5.09e-07	4.21e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—IL6—prostate cancer	5.08e-07	4.2e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—IL6—prostate cancer	5.08e-07	4.2e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—MYC—prostate cancer	5.08e-07	4.2e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TGFB1—prostate cancer	5.08e-07	4.2e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TGFB1—prostate cancer	5.06e-07	4.19e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—MYC—prostate cancer	5.06e-07	4.18e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—EGFR—prostate cancer	5.06e-07	4.18e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TGFB1—prostate cancer	5.05e-07	4.17e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—MYC—prostate cancer	5.04e-07	4.17e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—EP300—prostate cancer	5.04e-07	4.17e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TGFB1—prostate cancer	5.03e-07	4.16e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—VEGFA—prostate cancer	5.03e-07	4.16e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CB—prostate cancer	5.02e-07	4.15e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—EP300—prostate cancer	5.01e-07	4.15e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PPARA—prostate cancer	5e-07	4.14e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—PIK3CA—prostate cancer	5e-07	4.13e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—MYC—prostate cancer	5e-07	4.13e-06	CbGpPWpGaD
Amitriptyline—CHRM5—Signaling Pathways—AKT1—prostate cancer	4.98e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TGFB1—prostate cancer	4.98e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—MYC—prostate cancer	4.98e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—STAT3—prostate cancer	4.98e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CB—prostate cancer	4.98e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTGS2—prostate cancer	4.98e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—EGFR—prostate cancer	4.98e-07	4.12e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—PIK3CA—prostate cancer	4.97e-07	4.11e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TGFB1—prostate cancer	4.97e-07	4.11e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—EGFR—prostate cancer	4.97e-07	4.11e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—EGFR—prostate cancer	4.95e-07	4.09e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTGS2—prostate cancer	4.93e-07	4.08e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—EGFR—prostate cancer	4.93e-07	4.08e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—EGFR—prostate cancer	4.89e-07	4.04e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CD—prostate cancer	4.88e-07	4.04e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—EGFR—prostate cancer	4.87e-07	4.03e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—TP53—prostate cancer	4.84e-07	4e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—TP53—prostate cancer	4.81e-07	3.98e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—KRAS—prostate cancer	4.78e-07	3.95e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—PIK3CA—prostate cancer	4.76e-07	3.94e-06	CbGpPWpGaD
Amitriptyline—OPRM1—Signaling Pathways—AKT1—prostate cancer	4.73e-07	3.91e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PTEN—prostate cancer	4.72e-07	3.9e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CAV1—prostate cancer	4.71e-07	3.89e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—KRAS—prostate cancer	4.7e-07	3.89e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—PIK3CA—prostate cancer	4.7e-07	3.89e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—KRAS—prostate cancer	4.69e-07	3.88e-06	CbGpPWpGaD
Amitriptyline—ADRA1D—Signaling Pathways—AKT1—prostate cancer	4.69e-07	3.88e-06	CbGpPWpGaD
Amitriptyline—DRD3—Signaling Pathways—AKT1—prostate cancer	4.69e-07	3.88e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—KRAS—prostate cancer	4.68e-07	3.87e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—KRAS—prostate cancer	4.66e-07	3.85e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—MYC—prostate cancer	4.63e-07	3.83e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TGFB1—prostate cancer	4.62e-07	3.82e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—KRAS—prostate cancer	4.62e-07	3.82e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—NOS3—prostate cancer	4.61e-07	3.81e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PTEN—prostate cancer	4.61e-07	3.81e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—TP53—prostate cancer	4.61e-07	3.81e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—KRAS—prostate cancer	4.6e-07	3.81e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—EGFR—prostate cancer	4.53e-07	3.74e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—EP300—prostate cancer	4.5e-07	3.72e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—IL6—prostate cancer	4.43e-07	3.66e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—PIK3CA—prostate cancer	4.41e-07	3.64e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—IL6—prostate cancer	4.4e-07	3.64e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—EP300—prostate cancer	4.39e-07	3.63e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—PIK3CA—prostate cancer	4.39e-07	3.63e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PTEN—prostate cancer	4.34e-07	3.59e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—PIK3CA—prostate cancer	4.32e-07	3.57e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—PIK3CA—prostate cancer	4.32e-07	3.57e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—PIK3CA—prostate cancer	4.31e-07	3.56e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—PIK3CA—prostate cancer	4.31e-07	3.56e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PTEN—prostate cancer	4.3e-07	3.56e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—PIK3CA—prostate cancer	4.3e-07	3.55e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CG—prostate cancer	4.29e-07	3.54e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—PIK3CA—prostate cancer	4.28e-07	3.54e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—KRAS—prostate cancer	4.28e-07	3.54e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CB—prostate cancer	4.26e-07	3.52e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—TP53—prostate cancer	4.25e-07	3.51e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—PIK3CA—prostate cancer	4.24e-07	3.51e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—PIK3CA—prostate cancer	4.23e-07	3.5e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTGS2—prostate cancer	4.22e-07	3.49e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—IL6—prostate cancer	4.22e-07	3.49e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Metabolism—AKT1—prostate cancer	4.18e-07	3.46e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—TP53—prostate cancer	4.18e-07	3.46e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—TP53—prostate cancer	4.17e-07	3.45e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—TP53—prostate cancer	4.16e-07	3.44e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—TP53—prostate cancer	4.14e-07	3.43e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—EP300—prostate cancer	4.14e-07	3.42e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—EP300—prostate cancer	4.1e-07	3.39e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—TP53—prostate cancer	4.1e-07	3.39e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—TP53—prostate cancer	4.09e-07	3.38e-06	CbGpPWpGaD
Amitriptyline—HTR1A—Signaling Pathways—AKT1—prostate cancer	4.08e-07	3.38e-06	CbGpPWpGaD
Amitriptyline—HTR2C—Signaling Pathways—AKT1—prostate cancer	4.06e-07	3.36e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—INS—prostate cancer	4.06e-07	3.36e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—CREBBP—prostate cancer	3.97e-07	3.29e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—PIK3CA—prostate cancer	3.93e-07	3.25e-06	CbGpPWpGaD
Amitriptyline—ADRA1B—Signaling Pathways—AKT1—prostate cancer	3.89e-07	3.22e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—IL6—prostate cancer	3.89e-07	3.21e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Metabolism—AKT1—prostate cancer	3.84e-07	3.17e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—IL6—prostate cancer	3.82e-07	3.16e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—IL6—prostate cancer	3.82e-07	3.16e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—IL6—prostate cancer	3.8e-07	3.15e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—TP53—prostate cancer	3.8e-07	3.14e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—IL6—prostate cancer	3.79e-07	3.14e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CD—prostate cancer	3.77e-07	3.12e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—IL6—prostate cancer	3.76e-07	3.11e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—IL6—prostate cancer	3.75e-07	3.1e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—PIK3CA—prostate cancer	3.73e-07	3.08e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—PIK3CA—prostate cancer	3.71e-07	3.07e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PTEN—prostate cancer	3.68e-07	3.04e-06	CbGpPWpGaD
Amitriptyline—CYP2B6—Metabolism—AKT1—prostate cancer	3.6e-07	2.98e-06	CbGpPWpGaD
Amitriptyline—DRD2—Signaling Pathways—AKT1—prostate cancer	3.59e-07	2.97e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—NOS3—prostate cancer	3.56e-07	2.94e-06	CbGpPWpGaD
Amitriptyline—HTR2A—Signaling Pathways—AKT1—prostate cancer	3.53e-07	2.92e-06	CbGpPWpGaD
Amitriptyline—CYP2E1—Metabolism—AKT1—prostate cancer	3.53e-07	2.92e-06	CbGpPWpGaD
Amitriptyline—HRH1—Signaling Pathways—AKT1—prostate cancer	3.52e-07	2.91e-06	CbGpPWpGaD
Amitriptyline—CYP3A5—Metabolism—AKT1—prostate cancer	3.52e-07	2.91e-06	CbGpPWpGaD
Amitriptyline—CHRM1—Signaling Pathways—AKT1—prostate cancer	3.51e-07	2.9e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—EP300—prostate cancer	3.51e-07	2.9e-06	CbGpPWpGaD
Amitriptyline—CHRM3—Signaling Pathways—AKT1—prostate cancer	3.5e-07	2.89e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—IL6—prostate cancer	3.48e-07	2.88e-06	CbGpPWpGaD
Amitriptyline—CHRM2—Signaling Pathways—AKT1—prostate cancer	3.46e-07	2.86e-06	CbGpPWpGaD
Amitriptyline—ADRA1A—Signaling Pathways—AKT1—prostate cancer	3.45e-07	2.86e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—PIK3CA—prostate cancer	3.33e-07	2.75e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CB—prostate cancer	3.28e-07	2.72e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTGS2—prostate cancer	3.25e-07	2.69e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—PIK3CA—prostate cancer	3.25e-07	2.69e-06	CbGpPWpGaD
Amitriptyline—ADRA2A—Signaling Pathways—AKT1—prostate cancer	3.21e-07	2.65e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—PIK3CA—prostate cancer	3.06e-07	2.53e-06	CbGpPWpGaD
Amitriptyline—CYP2C8—Metabolism—AKT1—prostate cancer	3.05e-07	2.52e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—PIK3CA—prostate cancer	3.04e-07	2.51e-06	CbGpPWpGaD
Amitriptyline—ALB—Metabolism—AKT1—prostate cancer	3.03e-07	2.51e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PTEN—prostate cancer	2.84e-07	2.35e-06	CbGpPWpGaD
Amitriptyline—CYP2C19—Metabolism—AKT1—prostate cancer	2.72e-07	2.25e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—EP300—prostate cancer	2.71e-07	2.24e-06	CbGpPWpGaD
Amitriptyline—ABCB1—Metabolism—AKT1—prostate cancer	2.65e-07	2.2e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—PIK3CA—prostate cancer	2.59e-07	2.15e-06	CbGpPWpGaD
Amitriptyline—CYP2D6—Metabolism—AKT1—prostate cancer	2.5e-07	2.07e-06	CbGpPWpGaD
Amitriptyline—CYP2C9—Metabolism—AKT1—prostate cancer	2.48e-07	2.05e-06	CbGpPWpGaD
Amitriptyline—CYP1A2—Metabolism—AKT1—prostate cancer	2.12e-07	1.75e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—PIK3CA—prostate cancer	2e-07	1.66e-06	CbGpPWpGaD
Amitriptyline—CYP3A4—Metabolism—AKT1—prostate cancer	1.64e-07	1.35e-06	CbGpPWpGaD
